Impact of abemaciclib on the time to subsequent chemotherapy and the time to second disease progression across the MONARCH 2 and 3 studies Meeting Abstract
| Authors: | Tolaney, S. M.; Di Leo, A.; Llombart Cussac, A.; Dickler, M. N.; Campone, M.; Iwata, H.; Toi, M.; Kaufman, P. A.; Andre, V. A. M.; Barriga, S.; Goetz, M. P.; Sledge, G. W. |
| Abstract Title: | Impact of abemaciclib on the time to subsequent chemotherapy and the time to second disease progression across the MONARCH 2 and 3 studies |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 46s |
| Language: | English |
| ACCESSION: | WOS:000442916001070 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.1048 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1048 -- Source: Wos |
